Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment

Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders

(2010) Christian A. Heidbreder et al.   Annals of the New York Academy of Sciences

Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness

(2010) Anne Lesage et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures

(2010) Mark J. Millan et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Behavioral Indices in Antipsychotic Drug Discovery

(2010) R. D. Porsolt et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Enhanced cognitive performance of dopamine D3 receptor “knock-out” mice in the step-through passive-avoidance test: Assessing the role of the endocannabinoid/endovanilloid systems

(2010) Vincenzo Micale et al.   PHARMACOLOGICAL RESEARCH

The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat

(2010) Caitlin A. Jones et al.   PSYCHOPHARMACOLOGY

Chronic fluoxetine differentially modulates the hippocampal microtubular and serotonergic system in grouped and isolation reared rats

(2009) Massimiliano Bianchi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model

(2009) Beate Winner et al.   EXPERIMENTAL NEUROLOGY

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925

(2009) Ariel Graff-Guerrero et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

(2009) Stefania Risso Bradley et al.   NEUROPHARMACOLOGY

Cortico-Basal Ganglia Reward Network: Microcircuitry

(2009) Susan R Sesack et al.   NEUROPSYCHOPHARMACOLOGY

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

(2009) Jared W. Young et al.   PHARMACOLOGY & THERAPEUTICS

Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus

(2009) Massimiliano Bianchi et al.   SYNAPSE

Increased dopamine D2Highreceptors in rats reared in social isolation

(2009) Madeleine V. King et al.   SYNAPSE

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice

(2009) Eugenii A. Rabiner et al.   SYNAPSE

Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists

(2008) Florence Loiseau et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15

(2008) István Gyertyán et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function

(2008) Kevin C.F. Fone   NEUROPHARMACOLOGY

Dopaminergic Modulation of Risk-Based Decision Making

(2008) Jennifer R St Onge et al.   NEUROPSYCHOPHARMACOLOGY

Effects of social isolation rearing on the limbic brain: A combined behavioral and magnetic resonance imaging volumetry study in rats

(2008) M.I. Schubert et al.   NEUROSCIENCE

Object recognition memory: Neurobiological mechanisms of encoding, consolidation and retrieval

(2008) Boyer D. Winters et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Behavioural and neurochemical effects of post-weaning social isolation in rodents—Relevance to developmental neuropsychiatric disorders

(2008) Kevin C.F. Fone et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval

(2008) Vincent Pascoli et al.   PSYCHOPHARMACOLOGY

Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht6 receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task

(2008) M. V. King et al.   PSYCHOPHARMACOLOGY

Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138

(2008) Mark J. Millan et al.   THERAPIE

What Does the Anatomical Organization of the Entorhinal Cortex Tell Us?

(2008) Cathrin B. Canto et al.   NEURAL PLASTICITY